CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-11-18 | GRAZIANO JAMES JOSEPH Chief Technology Officer | Grant or award · Common Stock Option (right to buy) | +28,140 | 28,140 | ||
| 2014-06-13 | GRAZIANO JAMES JOSEPH Chief Technology Officer | Returned to the company · Series FA Warrants | −24,641 | 0 | ||
| 2014-06-13 | GRAZIANO JAMES JOSEPH Chief Technology Officer | Grant or award · Series FA Warrants | +24,641 | 24,641 | ||
| 2014-05-16 | GRAZIANO JAMES JOSEPH Chief Technology Officer | Grant or award | +104,386 | 104,386 | ||
| 2014-05-16 | GRAZIANO JAMES JOSEPH Chief Technology Officer | Grant or award · Warrant | +24,641 | 24,641 | ||
| 2014-05-16 | GRAZIANO JAMES JOSEPH Chief Technology Officer | Grant or award · Warrant | +807 | 807 | ||
| 2014-05-16 | GRAZIANO JAMES JOSEPH Chief Technology Officer | Grant or award · Warrant | +27,211 | 27,211 | ||
| 2014-05-16 | GRAZIANO JAMES JOSEPH Chief Technology Officer | Grant or award · Warrant | +76 | 76 | ||
| 2014-05-16 | GRAZIANO JAMES JOSEPH Chief Technology Officer | Grant or award · Warrant | +1,361 | 1,361 |
Page 1 of 1 · 9 trades